Skip to main content

Advertisement

Fig. 2 | Chinese Journal of Cancer

Fig. 2

From: New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

Fig. 2

Kaplan–Meier analysis estimated central nervous system (CNS) relapse-free survival for the 511 diffuse large B-cell lymphoma (DLBCL) patients stratified by independent risk factors. A low albumin (ALB) level at diagnosis (a), a high alkaline phosphatase (ALP) level (b), bone involvement (c), renal involvement (d), a lack of rituximab treatment (e), and a long time to complete remission (TTC) (f) were associated with short CNS relapse-free survival

Back to article page